Former AG Pam Bondi Recovering After Cancer Diagnosis
Planned Parenthood Expands Transgender Services
Desperate for Change—Day 33
Court Battles Over Biden’s Title IX Rewrite Come to an End
Intercessors Invited to Gather on Independence Day in DC
Former AG Pam Bondi Recovering After Cancer Diagnosis
Former Attorney General Pam Bondi is reportedly recovering from treatment for thyroid cancer just weeks after stepping down from the Department of Justice.
Let the IFA community know how to pray for you.
Bondi, 60, was diagnosed with thyroid cancer shortly after leaving the Justice Department, according to an Axios report Wednesday.
She is said to have undergone treatment in recent weeks and told CNN she is “doing well.”
President Donald Trump announced Bondi’s departure as attorney general in April and said she “will be transitioning to a much needed and important new job in the private sector, to be announced at a date in the near future.” After praising Bondi as a “great American patriot and a loyal friend” who “did a tremendous job,” he also criticized Bondi for failing to bring lawsuits against his perceived political foes.
She had also faced bipartisan criticism over her handling of documents related to convicted sex offender Jeffrey Epstein. Bondi [testified] before the House Oversight Committee on Jeffrey Epstein on Friday.
According to Axios, Trump has appointed Bondi to his Presidential Council of Advisors on Science and Technology (PCAST), a presidential panel established by executive order and co-chaired by former White House AI adviser David Sacks and White House science adviser Michael Kratsios. The council includes prominent tech executives such as Nvidia co-founder Jensen Huang, Meta CEO Mark Zuckerberg, Oracle co-founder Larry Ellison, and others, including Marc Andreessen, Sergey Brin and Lisa Su.
Created by a White House executive order in March, PCAST will work to advise the president on “strengthening American leadership in science and technology,” with a focus on “the opportunities and challenges that emerging technologies present to the American workforce, and ensuring all Americans thrive in the Golden Age of Innovation.”
Bondi will reportedly facilitate coordination between the Trump administration and the tech titans on the panel. She will also serve in a newly established advisory role on national infrastructure.
Composed of up to 24 members, PCAST will likely see additional members appointed in the near future, along with information about the council’s first meeting, according to Trump’s executive order.
Each president has established his own PCAST advisory committee of scientists, engineers, and industry leaders since President Franklin D. Roosevelt created his Science Advisory Board in 1933.
Bondi is the third Trump cabinet member to leave her post in the administration in recent weeks.
Last Friday, Director of National Intelligence Tulsi Gabbard announced in a resignation letter her decision to step down to care for her husband, who has a rare form of bone cancer.
“He faces major challenges in the coming weeks and months. At this time, I must step away from public service to be by his side and fully support him through this battle,” Gabbard wrote.
In March, Trump announced that U.S. Secretary of Homeland Security Kristi Noem was departing from her role to become the Special Envoy for the Shield of the Americas. She has since been replaced by former Sen. Markwayne Mullin, R-Okla., who was confirmed to the position by the U.S. Senate in a 54-45 vote last month.
Share your prayers for Bondi in the comments below.
This article was originally published at The Christian Post. Photo Credit: Department of Justice.
Partner with Us
Intercessors for America is the trusted resource for millions of people across the United States committed to praying for our nation. If you have benefited from IFA's resources and community, please consider joining us as a monthly support partner. As a 501(c)3 organization, it's through your support that all this possible.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy Policy


Comments
No comments have been posted yet; you can be the first!